Cargando…

Editorial: Interventional therapy of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Ji, Jiansong, Yang, Xiaoming, Luo, Jianyuan, Vucenik, Ivana, Jiang, Shuheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453639/ https://www.ncbi.nlm.nih.gov/pubmed/36090040 http://dx.doi.org/10.3389/fmolb.2022.972207

Ejemplares similares

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
por: Kumar, Vinay, et al.
Publicado: (2023)

ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma
por: Chen, Weiqian, et al.
Publicado: (2020)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
por: Zheng, Liyun, et al.
Publicado: (2021)

A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
por: Fang, Shiji, et al.
Publicado: (2021)

Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma
por: Wu, Lei, et al.
Publicado: (2020)

Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
por: Li, Xin, et al.
Publicado: (2021)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Case Report: One-Year Delay in the Effect of Conversion Surgery Therapy for Advanced Hepatocellular Carcinoma After Systemic Therapy
por: Xie, Qing-Yu, et al.
Publicado: (2022)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Xing-Wei, et al.
Publicado: (2021)

Editorial: Bioengineered Nanoparticles in Cancer Therapy
por: Zarrintaj, Payam, et al.
Publicado: (2021)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
por: Chen, Li, et al.
Publicado: (2021)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3
por: Li, Haoran, et al.
Publicado: (2021)

Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma Immunotherapy
por: Mo, Zhuomao, et al.
Publicado: (2020)

Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2021)

The Prognostic Value of Lysine Acetylation Regulators in Hepatocellular Carcinoma
por: Sun, Liying, et al.
Publicado: (2022)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

Molecular Associations and Clinical Significance of RAPs in Hepatocellular Carcinoma
por: Kumari, Sarita, et al.
Publicado: (2021)

Editorial: Bioengineered nanoparticles in cancer therapy, Volume II
por: Zarrintaj, Payam, et al.
Publicado: (2022)

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2022)

Expression of ALG3 in Hepatocellular Carcinoma and Its Clinical Implication
por: Zhao, Zhen, et al.
Publicado: (2022)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
por: Ke, Shanjia, et al.
Publicado: (2022)

Heat Shock Protein 60 in Hepatocellular Carcinoma: Insights and Perspectives
por: Hoter, Abdullah, et al.
Publicado: (2020)

Editorial: Advanced nanotechnology for reactive oxygen species-mediated therapies
por: Park, Chun Gwon, et al.
Publicado: (2022)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
por: Lin, Hongsheng, et al.
Publicado: (2021)

Editorial: Biology and Pharmacological Effects of Extracellular Vesicles in Cancer
por: Zhang, Jian-ye, et al.
Publicado: (2022)

Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib
por: Sun, Tao, et al.
Publicado: (2020)

Editorial: Tumor microenvironment in cancer hallmarks and therapeutics
por: Luo, Na
Publicado: (2022)

Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients
por: Liu, Jun, et al.
Publicado: (2022)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Tian, Yilin, et al.
Publicado: (2022)

Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Ma, Jiaxiu, et al.
Publicado: (2022)

Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis
por: Wu, Zhulin, et al.
Publicado: (2021)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Editorial: Molecular Targeted Therapy in Oncology: Lessons From Pharmacogenetics and Pharmacoepigenetics
por: Imani, Saber, et al.
Publicado: (2022)

Editorial: Drug Delivery System Based on Nanoparticles for Inflammation and Cancer Therapy
por: Zhang, Mingxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g60hcj6pi5r73lnli97u8pro50